Skip to main content
Premium Trial:

Request an Annual Quote

BGI Americas Collaborating With Champions Oncology on Proteomic Cancer Research

NEW YORK – BGI Americas said on Tuesday that it has entered a collaborative agreement with Champions Oncology to provide proteomics and multiomics tools for cancer biomarker discovery and validation.

Under the collaboration, BGI will provide mass spectrometry analysis of Champions' patient-derived xenograft samples to support biopharma drug discovery and development projects.

BGI will handle sample preparation and mass spec analysis, generating proteomics and metabolomic data out of its San Jose, California-based Mass Spectrometry Center. The collaboration will also give BGI's customers access to Champions' Lumin Bioinformatics platform, a data visualization software package that features more than 25,000 multiomic datasets.

"For years, BGI has worked with leading companies in the biopharmaceutical space, providing unmatched multiomics analysis services to support precision medicine studies and drug development at different phases," Siqi Liu, cofounder and global head of BGI’s Proteomics Center, said in a statement. "Leveraging deep expertise and 25 years of experience serving the biopharmaceutical and biotechnological industries, I am confident that this strategic partnership will deliver the unique information that customers truly need to make a difference in the fight against cancer."

Financial and other terms of the agreement were not disclosed.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more